| abstract |
The present invention relates to novel compounds of formula (I) having 11β-HSD type 1 antagonist activity and also to methods of preparing such compounds. In another embodiment, the present invention provides a pharmaceutical composition comprising a compound of formula (I), and also for treating diabetes, hyperglycemia, obesity, hypertension, hyperlipidemia, metabolic syndrome and other conditions associated with 11β-HSD type 1 activity. To methods of using the compounds and compositions for the same.n n n <Formula I> |